Financial News
Latest News about MRNA
Recent news which mentions MRNA
From Benzinga
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
August 04, 2022
From Benzinga
From Benzinga
Moderna, PayPal And Some Other Big Gainers From Wednesday
August 04, 2022
From Benzinga
From Motley Fool
From Benzinga
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
August 03, 2022
From Benzinga
Here's Why Novavax Shares Are Moving
August 03, 2022
From Benzinga
Here's Why BioNTech Stock Is Moving
August 03, 2022
From Benzinga
Moderna Just Gave Investors 499 Million Reasons to Worry
August 03, 2022
Tickers
MRNA
From Motley Fool
Biden’s isolation under White House protocols requires a negative test before in-person work. That’s stricter than the CDC guidelines.
August 03, 2022
From MarketWatch
From Benzinga
From Benzinga
Moderna (MRNA) Stock Pops on Strong Sales, Earnings Beat
August 03, 2022
From InvestorPlace
From Benzinga
Moderna Q2 Earnings: Earnings Beat, COVID-19 Inventory Write-Off, Additional Share Buyback
August 03, 2022
Tickers
MRNA
From Benzinga
Could This Unknown Stock Beat Moderna in 2023?
August 03, 2022
From Motley Fool
Keep running with the bond bulls says Bank of America
August 03, 2022
From MarketWatch
From Benzinga
From Benzinga
From Benzinga
Could the Fall Booster Market Boost Vaccine Stocks?
August 02, 2022
From Motley Fool
From Motley Fool
Target And Chevron Get CNBC Fast Money Mentions With Joe Terranova Rebalancing His ETF
August 01, 2022
From Benzinga
From Benzinga
Is The Energy Ready To Rebound?
August 01, 2022
From Benzinga
Could This News Change Everything for Moderna?
August 01, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
